European Journal of Internal Medicine
Volume 21, Issue 4 , Pages 289-292 , August 2010

Single nucleotide polymorphisms in inflammation-related genes are associated with venous thromboembolism

  • M.M.J. Beckers

      Affiliations

    • Department of Internal Medicine, St. Antonius Hospital Nieuwegein, The Netherlands
    • Corresponding Author InformationCorresponding author. Department of Hematology, Academic Medical Center, PO Box 22660, 1100 AZ Amsterdam, The Netherlands. Tel.: 020-5662649; fax 020-6919743.
  • ,
  • H.J.T. Ruven

      Affiliations

    • Department of Clinical Chemistry, St. Antonius Hospital Nieuwegein, The Netherlands
  • ,
  • F.J.L.M. Haas

      Affiliations

    • Department of Clinical Chemistry, St. Antonius Hospital Nieuwegein, The Netherlands
  • ,
  • P.A. Doevendans

      Affiliations

    • Department of Cardiology, University Medical Centre Utrecht, The Netherlands
  • ,
  • H. ten Cate

      Affiliations

    • Department of Internal Medicine, University Hospital Maastricht, The Netherlands
  • ,
  • M.H. Prins

      Affiliations

    • Department of Epidemiology, University of Maastricht, The Netherlands
  • ,
  • D.H. Biesma

      Affiliations

    • Department of Internal Medicine, University Medical Centre Utrecht, The Netherlands

Received 2 October 2009 ,Revised 8 March 2010 ,Accepted 5 April 2010.

References 

  1. van der Poll T, Levi M, Hack CE, ten Cate H, van Deventer SJ, et al. Elimination of interleukin 6 attenuates coagulation activation in experimental endotoxemia in chimpanzees. J Exp Med. 1994;179:1253–1259
  2. Reitsma PH, Rosendaal FR. Activation of innate immunity in patients with venous thrombosis: the Leiden Thrombophilia Study. J Thromb Haemost. 2004;2:619–622
  3. van Aken BE, Reitsma PH, Rosendaal FR. Interleukin 8 and venous thrombosis: evidence for a role of inflammation in thrombosis. Br J Haematol. 2002;116:173–177
  4. van Aken BE, den Heijer M, Bos GM, van Deventer SJ, Reitsma PH. Recurrent venous thrombosis and markers of inflammation. Thromb Haemost. 2000;83:536–539
  5. van der Poll T, de Jonge E, Levi M. Regulatory role in disseminated intravascular coagulation. Semin Thromb Hemost. 2001;27:639–651
  6. Trompet S, Pons D, De Craen AJ, Slagboom P, Shepherd J, Blauw GJ, et al. Genetic variation in the interleukin-10 gene promoter and risk of coronary and cerebrovascular events: the PROSPER study. Ann N Y Acad Sci. 2007;1100:189–198
  7. Wagner J, Kaminski WE, Aslanidis C, Moder D, Hiller KA, Christgau M, et al. Prevalence of OPG and IL-1 gene polymorphisms in chronic periodontitis. J Clin Periodontol. 2007;34:823–827
  8. Bagnoli S, Cellini E, Tedde A, Nacmias B, Piacentini S, Bessi V, et al. Association of IL10 promoter polymorphism in Italian Alzheimer's disease. Neurosci Lett. 2007;418:262–265
  9. Barcellos LF, Begovich AB, Reynolds RL, Caillier SJ, Brassat D, Schmidt S, et al. Linkage and association with the NOS2A locus on chromosome 17q11 in multiple sclerosis. Ann Neurol. 2004;55:793–800
  10. Kyrle PA, Minar E, Bialonczyk C, Hirschl M, Weltermann A, Eichinger S. The risk of recurrent venous thromboembolism in men and women. N Engl J Med. 2004;350:2558–2563
  11. McRae S, Tran H, Schulman S, Ginsberg J, Kearon C. Effect of patient's sex on risk of recurrent venous thromboembolism: a meta-analysis. Lancet. 2006;368:371–378
  12. Tsai AW, Cushman M, Rosamond WD, Heckbert SR, Polak JF, Folsom AR. Cardiovascular risk factors and venous thromboembolism incidence: the longitudinal investigation of thromboembolism etiology. Arch Intern Med. 2002;162:1182–1189
  13. Gangireddy C, Rectenwald JR, Upchurch GR, Wakefield TW, Khuri S, Henderson WG, et al. Risk factors and clinical impact of postoperative symptomatic venous thromboembolism. J Vasc Surg. 2007;45:335–342
  14. Keenan CR, White RH. The effects of race/ethnicity and sex on the risk of venous thromboembolism. Curr Opin Pulm Med. 2007;13:377–383
  15. van Eijk LT, Dorresteijn MJ, Smits P, van der Hoeven JG, Netea MG, Pickkers P. Gender differences in the innate immune response and vascular reactivity following the administration of endotoxin to human volunteers. Crit Care Med. 2007;35:1464–1469
  16. Wichmann MW, Inthorn D, Andress HJ, Schildberg FW. Incidence and mortality of severe sepsis in surgical intensive care patients: the influence of patient gender on disease process and outcome. Intensive Care Med. 2000;26:167–172
  17. Fishman D, Faulds G, Jeffery R, Mohamed-Ali V, Yudkin JS, Humphries S, et al. The effect of novel polymorphisms in the interleukin-6 (IL-6) gene on IL-6 transcription and plasma IL-6 levels, and an association with systemic-onset juvenile chronic arthritis. J Clin Invest. 1998;102:1369–1376
  18. Bennermo M, Held C, Stemme S, Ericsson CG, Silveira A, Green F, et al. Genetic predisposition of the interleukin-6 response to inflammation: implications for a variety of major diseases?. Clin Chem. 2004;50:2136–2140
  19. Dominici R, Cattaneo M, Malferrari G, Archi D, Mariani C, Grimaldi LM, et al. Cloning and functional analysis of the allelic polymorphism in the transcription regulatory region of interleukin-1 alpha. Immunogenetics. 2002;54:82–86
  20. Heesen M, Bloemeke B, Heussen N, Kunz D. Can the interleukin-6 response to endotoxin be predicted? Studies of the influence of a promoter polymorphism of the interleukin-6 gene, gender, the density of the endotoxin receptor CD14, and inflammatory cytokines. Crit Care Med. 2002;30:664–669
  21. Lynch EA, Dinarello CA, Cannon JG. Gender differences in IL-1α, IL1-β and IL-1 receptor antagonist secretion from mononuclear cells and urinary secretion. J Immunol. 1994;153:300–306
  22. Prandoni P. Link between arterial and venous disease. J Internal Medicine. 2007;262:341–350
  23. Zhang CQ, Huang H, Zhao Z, Tang XZ, Wang B, He F, et al. Gene expression profile related to inflammation in rat model of traumatic deep vein thrombosis. Chin J Traumatol. 2007;10:206–212
  24. Orbe J, Chordá C, Montes R, Páramo JA. Changes in the fibrinolytic components of cultured human umbilical vein endothelial cells induced by endotoxin, tumor necrosis factor-alpha and interleukin-1alpha. Haematologica. 1999;84:306–311
  25. ten Cate JW, van der Poll T, Levi M, ten Cate H, van Deventer SJ. Cytokines: triggers of clinical thrombotic disease. Thromb Haemost. 1997;78:415–419
  26. Osnes LT, Westvik AB, Joø GB, Okkenhaug C, Kierulf P. Inhibition of IL-1 induced tissue factor (TF) synthesis and procoagulant activity (PCA) in purified human monocytes by IL-4, IL-10 and IL-13. Cytokine. 1996;8:822–827
  27. Smiley ST, Boyer SN, Heeb MJ, Griffin JH, Grusby MJ. Protein S is inducible by interleukin 4 in T cells and inhibits lymphoid cell procoagulant activity. Proc Natl Acad Sci U S A. 1997;94:11484–11489
  28. Silander K, Alanne M, Kristiansson K, Saarela O, Ripatti S, Auro K, et al. Gender differences in genetic risk profiles for cardiovascular disease. PLoS ONE. 2008;3(10):e3615
  29. Brull DJ, Montgomery HE, Sanders J, Dhamrait S, Luong L, Rumley A, et al. Interleukin-6 gene −174g>c and −572g>c promoter polymorphisms are strong predictors of plasma interleukin-6 levels after coronary artery bypass surgery. Arterioscler Thromb Vasc Biol. 2001;21:1458–1463
  30. Vormittag R, Hsieh K, Kaider A, Minar E, Bialonczyk C, Hirschl M, et al. Interleukin-6 and interleukin-6 promoter polymorphism (−174) G>C in patients with spontaneous venous thromboembolism. Thromb Haemost. 2006;95:802–806
  31. Zangari M, Saghafifar F, Mehta P, Barlogie B, Fink L, Tricot G. The blood coagulation mechanism in multiple myeloma. Semin Thromb Hemost. 2003;29:275–282
  32. Reitsma PH, Rosendaal FR. Activation of innate immunity in patients with venous thrombosis: the Leiden Thrombophilia Study. J Thromb Haemost. 2004;2:619–622
  33. Christiansen SC, Naess IA, Cannegieter SC, Hammerstrøm J, Rosendaal FR, Reitsma PH. Inflammatory cytokines as risk factors for a first venous thrombosis: a prospective population-based study. PLoS Med. 2006;3:e334

PII: S0953-6205(10)00062-2

doi: 10.1016/j.ejim.2010.04.001

European Journal of Internal Medicine
Volume 21, Issue 4 , Pages 289-292 , August 2010